文献速递神经技术与安全PETCT

COVID-19后脑部[18F]FDG-PET表现:美国单中心回顾性研究

Post-COVID-19 Brain [18F] FDG-PET Findings: A Retrospective Single-Center Study in the United States.
PubMed 文献 · AJNR Am J Neuroradiol · 2023-04-27

本研究回顾性分析45例COVID-19感染后患者脑部[18F]FDG-PET/CT,其中15例有感染前基线扫描,并与52例肿瘤对照组比较。结果显示感染后早期出现双侧额顶枕后颞叶及小脑低代谢,2-6个月出现脑干、小脑、边缘系统、额叶皮层及脑室旁白质高代谢,低代谢在6个月接近完全恢复,12个月消失,且年龄、神经系统症状及疾病严重程度与代谢改变正相关。

要点

  • COVID-19后脑PET可见时间依赖性低代谢与高代谢模式,低代谢主要累及双侧额顶枕后颞叶及小脑。
  • 高代谢主要见于感染后2-6个月,累及脑干、小脑、边缘系统、额叶皮层及脑室旁白质。
  • 低代谢在感染后6个月接近完全恢复,12个月消失,提示代谢改变可随时间逆转。

关键影像表现/征象

  • 低代谢在感染后前2个月达峰,约6个月接近完全恢复,12个月消失。
  • 感染后2-6个月观察到脑干、小脑、边缘结构、额叶皮层及脑室旁白质高代谢。

临床应用与阅片要点

  • 阅片时需结合感染时间窗解读脑PET代谢改变,避免将可逆性低代谢误判为神经退行性疾病。
  • 对COVID-19后患者报告脑PET时,可提示双侧额顶枕后颞叶及小脑低代谢模式,并注明与感染时间的关联。
  • 感染后2-6个月出现脑干、小脑、边缘系统等高代谢时,需考虑COVID-19相关代谢改变而非肿瘤或炎症。

局限性

  • 回顾性单中心设计,样本量有限(45例患者,仅15例有感染前基线)。
  • 对照组为肿瘤患者,可能存在基础疾病对脑代谢的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The pathophysiology of neurologic manifestations of postacute sequelae of Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection is not clearly understood. Our aim was to investigate brain metabolic activity on [18F] FDG-PET/CT scans in patients with a history of coronavirus disease 2019 (COVID-19) infection before imaging.

MATERIALS AND METHODS: This retrospective study included 45 patients who underwent [18F] FDG-PET/CT imaging for any reason and had, at least once, tested positive for COVID-19 at any time before imaging. Fifteen patients had available [18F] FDG-PET scans obtained under identical conditions before the infection. A group of 52 patients with melanoma or multiple myeloma who underwent [18F] FDG-PET/CT were used as controls. Whole-brain 2-sample t test analysis was performed using SPM software to identify clusters of hypo- and hypermetabolism and compare brain metabolic activity between patients with COVID-19 and controls. Paired sample t test comparison was also performed for 15 patients, and correlations between metabolic values of clusters and clinical data were measured.

RESULTS: Compared with the control group, patients with a history of COVID-19 infection exhibited focal areas of hypometabolism in the bilateral frontal, parietal, occipital, and posterior temporal lobes and cerebellum (P = .05 uncorrected at the voxel level, family-wise error-corrected at the cluster level) that peaked during the first 2 months, improved to near-complete recovery around 6 months, and disappeared at 12 months. Hypermetabolism involving the brainstem, cerebellum, limbic structures, frontal cortex, and periventricular white matter was observed only at 2-6 months after infection. Older age, neurologic symptoms, and worse disease severity scores positively correlated with the metabolic changes.

CONCLUSIONS: This study demonstrates a profile of time-dependent brain PET hypo- and hypermetabolism in patients with confirmed SARS-CoV-2 infection.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Debs, Khalili, Solnes, et al. Post-COVID-19 Brain [18F] FDG-PET Findings: A Retrospective Single-Center Study in the United States. AJNR Am J Neuroradiol. 2023. PMID: 37105680. doi:10.3174/ajnr.A7863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。